Hussman Strategic Advisors’s GSK GSK Stock Holding History

Hussman Strategic Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-40,000	Closed	-$2.16M	–	201
2016 Q3	$2.16M	Buy	+40,000	New	+$2.19M	0.36%	91
2015 Q1	–	Sell	-240,000	Closed	-$12.8M	–	198
2014 Q4	$12.8M	Sell	240,000 -18,800	-7%	-$1.05M	1.28%	20
2014 Q3	$14.9M	Hold	258,800	–	–	1.27%	12
2014 Q2	$17.3M	Hold	258,800	–	–	1.33%	17
2014 Q1	$17.3M	Sell	258,800 -80,000	-24%	-$5.41M	1.3%	25
2013 Q4	$22.6M	Buy	338,800 +320,000	+1,702%	+$20.7M	1.61%	4
2013 Q3	$1.18M	Hold	18,800	–	–	0.06%	137
2013 Q2	$1.17M	Buy	+18,800	New	+$1.19M	0.05%	149

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hussman Strategic Advisors's GSK Position: Q4 2016 in Review

Hussman Strategic Advisors sold out of GSK (GSK) in Q4 2016, closing a stake of 40,000 shares — an estimated $2.16M sold.

Hussman Strategic Advisors first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $22.6M in Q4 2013. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Hussman Strategic Advisors reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
Hussman Strategic Advisors sold 40,000 GSK shares in Q4 2016, an estimated $2.16M.
Hussman Strategic Advisors first reported a position in GSK in Q2 2013 and held it in 8 quarters.
Hussman Strategic Advisors's GSK position peaked at $22.6M in Q4 2013.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Hussman Strategic Advisors's 13F filing for Q4 2016, filed 1 Feb 2017.